Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study
- PMID: 25995241
- PMCID: PMC4442191
- DOI: 10.1136/bmjopen-2015-007806
Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study
Abstract
Objective: To determine if comorbid asthma is associated with accumulation of multiple sclerosis (MS)-related impairment and disability.
Method: We sent a comprehensive questionnaire to a cohort of patients with MS and examined the association between comorbid asthma and reaching Expanded Disability Status Scale (EDSS) scores 4.0 and 6.0. Multiple Sclerosis Impact Scale (MSIS-29) scores were compared between patients with MS with and without comorbid asthma.
Results: 680 patients participated in our study of whom 88 (12.9%) had comorbid asthma. There was no difference in the prevalence of asthma between our MS cohort and the England general population (OR: 0.89, 95% CI 0.68 to 1.17). We did not observe a significant association between having asthma and the risk of reaching EDSS scores 4.0 and 6.0 (HR: 1.29, 95% CI 0.93 to 1.77, and HR: 1.33, 95% CI 0.93 to 1.89, respectively) after controlling for confounders. Patients with MS with asthma reported higher level of psychological impairments (coefficient: 2.29, 95% CI 0.1 to 4.49).
Conclusions: Asthma is a prevalent condition among patients with MS and it may contribute to the psychological impairment in MS. Although we did not observe significant association between comorbid asthma and physical disability in MS, it seems that the two conditions influence one another.
Keywords: EPIDEMIOLOGY.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Figures


Similar articles
-
Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.Mult Scler. 2004 Oct;10(5):569-74. doi: 10.1191/1352458504ms1078oa. Mult Scler. 2004. PMID: 15471375
-
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.Health Technol Assess. 2015 Feb;19(12):vii-viii, xxv-xxxi, 1-187. doi: 10.3310/hta19120. Health Technol Assess. 2015. PMID: 25676540 Free PMC article. Clinical Trial.
-
Concomitant autoimmunity and risk of multiple sclerosis disability worsening.Mult Scler Relat Disord. 2024 Jul;87:105637. doi: 10.1016/j.msard.2024.105637. Epub 2024 May 1. Mult Scler Relat Disord. 2024. PMID: 38761694
-
Smoking and worsening disability in multiple sclerosis: A meta-analysis.Acta Neurol Scand. 2018 Jul;138(1):62-69. doi: 10.1111/ane.12916. Epub 2018 Mar 15. Acta Neurol Scand. 2018. PMID: 29542102
-
Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.
Cited by
-
A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.J Neurol. 2021 Nov;268(11):4066-4077. doi: 10.1007/s00415-020-10107-y. Epub 2020 Jul 27. J Neurol. 2021. PMID: 32719975 Free PMC article.
-
Challenges in the management of severe allergic asthma in the elderly.J Asthma Allergy. 2016 Mar 17;9:55-63. doi: 10.2147/JAA.S85420. eCollection 2016. J Asthma Allergy. 2016. PMID: 27051308 Free PMC article. Review.
-
Comorbidities in multiple sclerosis-a plea for interdisciplinary collaboration to improve the quality of life of MS patients.Degener Neurol Neuromuscul Dis. 2019 Jun 13;9:39-53. doi: 10.2147/DNND.S204555. eCollection 2019. Degener Neurol Neuromuscul Dis. 2019. PMID: 31354380 Free PMC article.
-
House dust mite-induced asthma exacerbates Alzheimer's disease changes in the brain of the AppNL-G-F mouse model of disease.Brain Behav Immun. 2024 Oct;121:365-383. doi: 10.1016/j.bbi.2024.07.038. Epub 2024 Jul 29. Brain Behav Immun. 2024. PMID: 39084541 Free PMC article.
-
Investigating the Effect of Cigarette Smoking on Serum Uric Acid Levels in Multiple Sclerosis Patients: A Cross Sectional Study.Brain Sci. 2023 May 15;13(5):800. doi: 10.3390/brainsci13050800. Brain Sci. 2023. PMID: 37239272 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical